{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:14:29Z","timestamp":1790252069751,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014417","name":"Fundamental Research Fund of Shandong University","doi-asserted-by":"publisher","award":["2018JC016"],"award-info":[{"award-number":["2018JC016"]}],"id":[{"id":"10.13039\/100014417","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020QH243"],"award-info":[{"award-number":["ZR2020QH243"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022MH317"],"award-info":[{"award-number":["ZR2022MH317"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303905"],"award-info":[{"award-number":["82303905"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172818"],"award-info":[{"award-number":["82172818"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302946"],"award-info":[{"award-number":["82302946"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972416"],"award-info":[{"award-number":["81972416"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.neo.2024.100983","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T06:13:06Z","timestamp":1709014386000},"page":"100983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Identification of recurrent BRAF non-V600 mutations in intraductal carcinoma of the prostate in Chinese populations"],"prefix":"10.1016","volume":"50","author":[{"given":"Jing","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9866-3029","authenticated-orcid":false,"given":"Xiaorong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2024.100983_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.neo.2024.100983_bib0002","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"Cancer genome atlas research N. the molecular taxonomy of primary prostate cancer","volume":"163","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neo.2024.100983_bib0003","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41586-020-2135-x","article-title":"A genomic and epigenomic atlas of prostate cancer in Asian populations","volume":"580","author":"Li","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.neo.2024.100983_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00064","article-title":"Beyond the androgen receptor: targeting actionable drivers of prostate cancer","volume":"1","author":"Nelson","year":"2017","journal-title":"JCo Precis. Oncol."},{"key":"10.1016\/j.neo.2024.100983_bib0005","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm.2166","article-title":"Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma","volume":"16","author":"Palanisamy","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.neo.2024.100983_bib0006","doi-asserted-by":"crossref","first-page":"418","DOI":"10.5858\/arpa.2011-0519-RA","article-title":"Intraductal carcinoma of the prostate","volume":"136","author":"Robinson","year":"2012","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.neo.2024.100983_bib0007","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.eururo.2017.03.013","article-title":"Systematic review links the prevalence of intraductal carcinoma of the prostate to prostate cancer risk categories","volume":"72","author":"Porter","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.neo.2024.100983_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152693","article-title":"Prognostic significance of the presence of intraductal carcinoma of the prostate and bone metastasis in needle biopsy for prostate carcinoma patients with grade group 5","volume":"216","author":"Chen","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.neo.2024.100983_bib0009","doi-asserted-by":"crossref","first-page":"13671","DOI":"10.1038\/ncomms13671","article-title":"Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories","volume":"8","author":"Taylor","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2024.100983_bib0010","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/PAS.0b013e3181d6827b","article-title":"ETS gene aberrations in atypical cribriform lesions of the prostate: implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial Neoplasia","volume":"34","author":"Han","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.neo.2024.100983_bib0011","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/path.4628","article-title":"Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization","volume":"238","author":"Haffner","year":"2016","journal-title":"J. Pathol."},{"key":"10.1016\/j.neo.2024.100983_bib0012","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.eururo.2014.09.006","article-title":"Tracking the origin of metastatic prostate cancer","volume":"67","author":"Lindberg","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.neo.2024.100983_bib0013","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1038\/s41467-022-33780-1","article-title":"Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease","volume":"13","author":"Wong","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2024.100983_bib0014","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.eururo.2017.04.034","article-title":"A prostate cancer \"nimbosus\": genomic instability and SChLAP1 dysregulation underpin aggression of intraductal and cribriform subpathologies","volume":"72","author":"Chua","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.neo.2024.100983_bib0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12885-017-3976-z","article-title":"Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations","volume":"18","author":"Bottcher","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.neo.2024.100983_bib0016","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.juro.2010.06.017","article-title":"Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings","volume":"184","author":"Robinson","year":"2010","journal-title":"J. Urol."},{"key":"10.1016\/j.neo.2024.100983_bib0017","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"Grasso","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neo.2024.100983_bib0018","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.1073\/pnas.1902651116","article-title":"Genomic correlates of clinical outcome in advanced prostate cancer","volume":"116","author":"Abida","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neo.2024.100983_bib0019","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nm.4053","article-title":"Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer","volume":"22","author":"Kumar","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.neo.2024.100983_bib0020","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1158\/1078-0432.CCR-20-0168","article-title":"Oncogenic genomic alterations, clinical phenotypes, and outcomes in metastatic castration-sensitive prostate cancer","volume":"26","author":"Stopsack","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2024.100983_bib0021","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.neo.2024.100983_bib0022","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.eururo.2017.08.027","article-title":"Whole-genome and transcriptome sequencing of prostate cancer identify new genetic alterations driving disease progression","volume":"73","author":"Ren","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.neo.2024.100983_bib0023","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nature20788","article-title":"Genomic hallmarks of localized, non-indolent prostate cancer","volume":"541","author":"Fraser","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neo.2024.100983_bib0024","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1038\/s41467-022-30003-5","article-title":"Alterations in homologous recombination repair genes in prostate cancer brain metastases","volume":"13","author":"Rodriguez-Calero","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2024.100983_bib0025","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1002\/imt2.36","article-title":"Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform","volume":"1","author":"Shen","year":"2022","journal-title":"iMeta"},{"key":"10.1016\/j.neo.2024.100983_bib0026","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13046-019-1222-z","article-title":"BTF3 sustains cancer stem-like phenotype of prostate cancer via stabilization of BMI1","volume":"38","author":"Hu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.neo.2024.100983_bib0027","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/cncr.31959","article-title":"Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer","volume":"125","author":"Sonpavde","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.neo.2024.100983_bib0028","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1158\/1078-0432.CCR-21-2577","article-title":"Differences in prostate cancer genomes by self-reported race: contributions of genetic ancestry, modifiable cancer risk factors, and clinical factors","volume":"28","author":"Stopsack","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2024.100983_bib0029","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41588-018-0078-z","article-title":"The long tail of oncogenic drivers in prostate cancer","volume":"50","author":"Armenia","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neo.2024.100983_bib0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12916-022-02430-0","article-title":"Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P)","volume":"20","author":"Zhu","year":"2022","journal-title":"BMC Med."},{"key":"10.1016\/j.neo.2024.100983_bib0031","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1158\/2159-8290.CD-12-0097","article-title":"BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors","volume":"2","author":"Dahlman","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.neo.2024.100983_bib0032","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cell.2019.01.025","article-title":"Widespread and functional RNA circularization in localized prostate cancer","volume":"176","author":"Chen","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.neo.2024.100983_bib0033","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.eururo.2021.03.009","article-title":"Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy","volume":"80","author":"Wilkinson","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.neo.2024.100983_bib0034","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1158\/1078-0432.CCR-21-2138","article-title":"Molecular pathways and mechanisms of BRAF in CANCER THERapy","volume":"28","author":"Poulikakos","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2024.100983_bib0035","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1158\/1078-0432.CCR-23-1393","article-title":"Unique spectrum of activating BRAF alterations in prostate cancer","volume":"29","author":"Chehrazi-Raffle","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2024.100983_bib0036","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.trecan.2021.04.009","article-title":"Co-occurrence and mutual exclusivity: what cross-cancer mutation patterns can tell us","volume":"7","author":"El Tekle","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.neo.2024.100983_bib0037","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41467-020-20820-x","article-title":"Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer","volume":"12","author":"Bernasocchi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2024.100983_bib0038","doi-asserted-by":"crossref","first-page":"e3949","DOI":"10.1371\/journal.pone.0003949","article-title":"BRAF activation initiates but does not maintain invasive prostate adenocarcinoma","volume":"3","author":"Jeong","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2024.100983_bib0039","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/his.14224","article-title":"PIN-like ductal carcinoma of the prostate has frequent activating RAS\/RAF mutations","volume":"78","author":"Kaur","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.neo.2024.100983_bib0040","article-title":"Genomic and evolutionary characterization of concurrent intraductal carcinoma and adenocarcinoma of the prostate","author":"Zhao","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2024.100983_bib0041","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.eururo.2014.08.007","article-title":"Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis","volume":"67","author":"Risbridger","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.neo.2024.100983_bib0042","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41391-019-0134-5","article-title":"MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer","volume":"22","author":"Nickols","year":"2019","journal-title":"Prostate Cancer Prostatic. Dis."},{"key":"10.1016\/j.neo.2024.100983_bib0043","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1038\/s41388-022-02332-8","article-title":"RUVBL1 promotes enzalutamide resistance of prostate tumors through the PLXNA1-CRAF-MAPK pathway","volume":"41","author":"Sun","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2024.100983_bib0044","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1038\/s41388-018-0171-x","article-title":"Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations","volume":"37","author":"Dankner","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2024.100983_bib0045","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrc2402","article-title":"Recurrent gene fusions in prostate cancer","volume":"8","author":"Kumar-Sinha","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neo.2024.100983_bib0046","doi-asserted-by":"crossref","first-page":"e84959","DOI":"10.1371\/journal.pone.0084959","article-title":"ERG rearrangement is associated with prostate cancer-related death in Chinese prostate cancer patients","volume":"9","author":"Qi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2024.100983_bib0047","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"161","author":"Robinson","year":"2015","journal-title":"Cell"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558624000204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558624000204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:13:49Z","timestamp":1761484429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558624000204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":47,"alternative-id":["S1476558624000204"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2024.100983","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of recurrent BRAF non-V600 mutations in intraductal carcinoma of the prostate in Chinese populations","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2024.100983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100983"}}